| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |